FONAR (FONR) has just posted its Q3 2026 results, with Q2 fiscal 2026 revenue at US$25.5 million and basic EPS of US$0.30, alongside a trailing twelve month net profit margin of 6.8%. Over recent quarters the company has seen revenue move between US$24.9 million and US$27.3 million, while quarterly basic EPS has ranged from US$0.11 to US$0.46, setting the backdrop for trailing twelve month EPS of about US$1.10. With earnings quality described as high but margins a touch softer than a year ago, some investors may focus on how these results relate to the durability of profitability.

See our full analysis for FONAR.

Next up, the numbers will be weighed against the dominant narratives around FONAR to see which stories still hold up and which expectations may need a reset.

6.8% margin points to pressure on profitability

• Over the last 12 months, FONAR converted US$106.0 million of revenue into US$7.2 million of net income, which works out to a 6.8% net profit margin compared with 7.3% a year earlier.
• Critics highlight the bearish point that reported earnings have declined at a 7.1% annual rate over five years, and the softer 6.8% margin against the prior 7.3% gives them concrete support:
  • The trailing twelve month net income of US$7.2 million is below the earlier US$9.1 million level in the provided history, which lines up with that multi year earnings decline.
  • Quarterly net income has bounced between about US$0.7 million and US$3.0 million over the last six reported quarters, so bears can point to an uneven profitability pattern rather than a steadily rising trend.

On this margin picture, skeptics may feel the long run earnings decline story still matters, especially with the latest 6.8% margin sitting below last year’s 7.3%. 🐻 FONAR Bear Case

TTM EPS of US$1.10 versus mixed valuation signals

• Trailing twelve month basic EPS sits at about US$1.10, and against a share price of US$18.86 that backs into a P/E of 17.2x, which is higher than the 15.3x peer average but below the 23.4x US Medical Equipment industry level.
• What stands out for the bearish narrative is the tension between that earnings trend and the valuation multiples, even as earnings are described as high quality:
  • The 7.1% annual decline in earnings over five years gives bears a concrete reason to question paying 17.2x trailing EPS when peers are priced lower at 15.3x.
  • At the same time, the stock trades below the broader industry multiple and carries a 6.8% margin with US$7.2 million of net income, which shows that investors are already paying less than the wider sector for that level of profitability.

DCF fair value of US$21.31 versus US$18.86 price

• The supplied DCF fair value of US$21.31 compares with a market price of US$18.86, so the stock is about 11.5% below that model while still reflecting a 17.2x P/E and 6.8% net margin.
• Bulls argue that a gap between price and DCF fair value can signal upside, and here the numbers give them some backing but also a few checks:
  • The roughly 11.5% discount to the DCF fair value sits alongside a P/E that is lower than the broader industry’s 23.4x, which supports the idea that the market may not be fully crediting the business relative to that benchmark.
  • However, the same valuation has to be weighed against the 7.1% annual decline in earnings and the step down in net margin from 7.3% to 6.8%, which keeps the bullish case tied closely to whether that DCF input set still holds.

For readers who want to see how other investors connect this valuation gap to FONAR’s long term story, check out the current community views on the stock through 📊 Read the what the Community is saying about FONAR..

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on FONAR's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

After weighing both the bullish and bearish angles, do these numbers leave you confident or cautious about FONAR? If you want to move quickly and base your view on more than headlines, it is worth understanding both sides of the argument with 1 key reward and 1 important warning sign.

Explore Alternatives

FONAR faces pressure from a five year earnings decline, softer margins at 6.8% versus 7.3%, and a P/E above closer peers despite that backdrop.

If that mix of weaker earnings momentum and a richer P/E makes you cautious, compare it with companies screened as 45 high quality undervalued stocks to see where the risk reward trade off could look more appealing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.